Clinical Trial Update: First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BCX7353 in Healthy Western and Japanese Volunteers [Phase 1]

View source ↗

Summary

First-in-human Phase 1 study evaluating BCX7353 for safety, tolerability, pharmacokinetics, and pharmacodynamics in healthy volunteers with hereditary angioedem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• BCX7353

Snippet

Sponsor: BioCryst Pharmaceuticals | Conditions: Hereditary Angioedema | Phase 1 | Status: COMPLETED